Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)

This is an announcement about a small grant specifically designed to support new investigators, with a focus on those from diverse backgrounds or groups that are underrepresented in biomedical research. The grant is provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and other participating Institutes and Centers. It primarily aims to fund small projects that align with NIDDK's scientific mission areas.

The grant, known as an R21 grant, is intended for new investigators who have received less than $125,000 in combined research funding, excluding National Institutes of Health (NIH) training and career awards. It is particularly suitable for projects that can be accomplished in a short amount of time using limited resources.

One of the main goals of the R21 grant is to ease the investigator's transition to research independence. It supports a range of different projects, including pilot and feasibility studies, secondary data analysis, small-scale research projects, research methodology development, and new research technology development. Clinical trials are optional under this grant.